Investing Profile
Kouki Harasaki
InvestorVCOperator
Healthcare & Life Sciences at M12 - Microsoft's Venture Fund
bioluminescence.comSan Francisco, California
Your Intro Paths to Kouki Harasaki
Signal uses Gmail to reveal intro paths. Email content is never read.
Sign in with Google →Networks Kouki is a member of
Harvard Business School Network
507 CONNECTIONS
IT CRUX Mobile Apps Solutions Network
397 CONNECTIONS
Cornell University Network
174 CONNECTIONS
University of Cambridge Network
131 CONNECTIONS
Andreessen Horowitz Network
106 CONNECTIONS
Find Kouki Harasaki on
cbCurrent Investing Position
M12 - Microsoft's Venture Fund Analyst
Investment Range
$2.0M - $10.0M
Sweet Spot
$6.0M
Investments On Record
7
Kouki Harasaki is on these Sector & Stage Rankings
Kouki Harasaki's Investments On Record (7)
| Company | StageDateRound Size | Total Raised |
|---|---|---|
Cerevance | Series BApr 2024$47M | $180M |
ReCode Therapeutics | Series BSep 2023$50M | $210M |
SURGE Therapeutics | Series BJul 2023$32M | $58M |
Ensoma | Series BMay 2023$50M | $260M |
Nido Biosciences | Series BMay 2023$87M | $87M |
Karlsgate | SeedMar 2022$4M | $4M |
Artificial | Series AMay 2021$22M | $22M |
Kouki Harasaki's Experience
Managing Director Ikigai BioVentures2025 - Present
Healthcare & Life Sciences M12 - Microsoft's Venture Fund2020 - Present
Managing Director IT CRUX Mobile Apps SolutionsPresent
Founding / Managing / General Partner Bioluminescence Ventures2022 - 2025
Board Observer GEMMA Biotherapeutics2024 - 2025
Board Director Cerevance2024 - 2025
Board Director ReCode Therapeutics2023 - 2025
Board Director SURGE Therapeutics2023 - 2025
Board Director Ensoma2023 - 2025
Board Director Nido Biosciences2023 - 2025
Board Observer Valo Health2022 - 2025
Founding & Managing Partner Bioluminescence Ventures2022 - 2025
Board Director Karlsgate2021 - 2022
Board Director 19102021 - 2022
Board Director Ozette2021 - 2022
Board Director Artificial, Inc.2021 - 2022
Board Observer Huue2021 - 2022
Board Advisor Code Ocean2021 - 2022
Board: Biotechnology Seed Capital Alexandria LaunchLabs2020 - 2022
Managing Director / Biotechnology Lead Investor M12, Microsoft's Venture Fund2020 - 2022
Venture Partner: Healthcare Strategy & Investment Lead Romulus Capital2020 - 2020
Partner, Bio Fund Andreessen Horowitz2018 - 2019
Chief Operating Officer & Chief Financial Officer Medal (part of Ciox)2016 - 2018
Blavatnik Fellow (Healthcare Entrepreneur-In-Residence) Harvard Business School2016 - 2017
Senior Director, Oncology Search/Evaluations/Transactions, Business Development & Licensing Baxalta2014 - 2016
Director, Transactions, Business Development & Licensing Novartis2012 - 2014
Director, Head of Finance, Business Development & Licensing Novartis2011 - 2012
CEO Chief of Staff, Vaccines & Diagnostics Novartis2011 - 2011
Consultant, Pipeline Strategy iPierian2011 - 2011
Consultant, Market Planning Dr. Reddy's Laboratories2010 - 2011
MBA Summer Associate, Oncology Business Development Genentech2010 - 2010
Consultant, Healthcare Venture Capital Sofinnova Investments2009 - 2009
Research Investigator, Cardiovascular & Metabolism R&D Novartis2006 - 2009
Wellcome Trust Fellow, Clinical Biochemistry University of Cambridge2001 - 2006
Undergraduate Researcher (Honors Thesis), Department of Molecular Medicine Cornell Law School2000 - 2001
Research Assistant | Lab of Cellular Physiology | National Heart, Lung, Blood Institute National Institutes of Health2000 - 2000
Clinical Research Assistant, Department of Cardiothoracic Surgery University Hospitals1999 - 1999
Clinical Research Assistant, Department of Cardiothoracic Surgery Cleveland Clinic1994 - 1996
Kouki Harasaki's Education
Harvard Business School MBA Healthcare and Finance
Cornell University BA Molecular/Cellular Biology & Asian Studies
University of Cambridge PhD Clinical Biochemistry
Investors who invest with Kouki Harasaki
Founders who looked at Kouki Harasaki's profile also looked at these Scouts & Angels